跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 46 条关于
“APOA1”
全部
46
临床试验
32
药物
5
机构
0
资讯
9
2个月前
Cognito Therapeutics Presents Exploratory Biomarker Data at AAIC 2026 Linking Spectris Neuromodulation to Lipid Transport and Myelination Pathways in Alzheimer's Disease
去年
Obicetrapib Shows Promise in Phase 3 BROADWAY Trial, Reduces LDL-C and MACE
去年
Metabolic Signatures Predict Immunotherapy Response in Metastatic Melanoma Patients
5个月前
Proteomic Blood Test Predicts Kidney Failure in APOL1 High-Risk Individuals Years Before Symptoms Emerge
去年
Maze Therapeutics Initiates Phase 2 Trial of MZE829 for APOL1 Kidney Disease
去年
Maze Therapeutics' MZE829 Shows Promise in Phase 1 Trial for APOL1 Kidney Disease
去年
Maze Therapeutics' MZE829 Shows Promise in Phase I Trial for APOL1 Kidney Disease
2年前
Inaxaplin Shows Promise in Addressing APOL1-Mediated Kidney Disease Disparity in Black Americans
2年前
ApoA-I Infusions Show Promise in Reducing Cardiovascular Events Post-MI, Especially in Patients with Lower LDL-C